Ikfe Institut Fur Klinische Forschung Und Entwicklung Gmbh

Other

Becton Dickinson and Company Limited

Mannkind Corporation

Andreas Pfuetzner

Thomas Forst

Anders Hasager Boss

Christoph Eckerskorn

Mikkel Nissum

Wayman Wendell Cheatham

The invention provides compositions and methods for determining insulin resistance and/or pancreatic &#x3b2;-cell dysfunction in a subject. The invention also provides compositions and methods for treating a subject according to the insulin resistance and/or pancreatic &#x3b2;-cell dysfunction in the subject.

Method of treating vascular insulin resistance in a normoglycemic subject based on biomarkers

The present invention provides diagnostic in vitro methods as well as kits and devices to be used in the methods of the present invention for diagnosis or prognosis of a pathologic condition characterized by the presence/absence of an endogenous hormone and/or hormone analog(s) thereof involved in diabetes or metabolic syndrome. The methods comprise a quantitative separation of at least those analytes of interest whose common presence interferes with measuring the presence/absence or concentration of one of the analytes of interest by a subsequent analytical method.

Method and system for measuring a sample to determine the presence of and optionally treat a pathologic condition

The invention provides compositions and methods for determining cardiodiabetes status in a subject. The invention also provides compositions and methods for treating a subject experiencing cardiodiabetes.

Biomarkers for cardiodiabetes

Method of treating a subject according to biomarkers for insulin resistance

Growing community of inventors

Mainz, Germany

Andreas Pfuetzner